BC Week In Review | Aug 22, 2016
Company News

Trovagene sales and marketing update

Trovagene said Blue Cross Blue Shield (BCBS) of Illinois will cover Trovagene’s Trovera liquid biopsy tests. The biotech markets Trovera EGFR , a non-invasive molecular diagnostic to detect EGFR exon 19 deletions and exon 20 T790M...
BC Week In Review | Apr 28, 2014
Clinical News

BRAF V600E oncogene mutation assay: Clinical trial data

Researchers at the University of Texas MD Anderson Cancer Center reported data from a prospective study in 33 patients whose biopsies had previously tested positive for BRAF V600E mutations by a CLIA-certified laboratory showed that...
Items per page:
1 - 2 of 2